{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T23:23:29Z","timestamp":1763767409812,"version":"build-2065373602"},"reference-count":45,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2022,7,22]],"date-time":"2022-07-22T00:00:00Z","timestamp":1658448000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"University of Minnesota"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Genes"],"abstract":"<jats:p>Mucopolysaccharidosis type I (MPS I) is a rare inherited lysosomal disorder caused by deficiency of the \u03b1-L-iduronidase enzyme, resulting in the progressive accumulation of glycosaminoglycans (GAGs), which interfere with the normal function of multiple tissues and organs. The clinical phenotype includes characteristic facial features, hepatosplenomegaly, dysostosis multiplex, umbilical and inguinal hernias, progressive cognitive deficits with corresponding hydrocephalus, and neuropathology. Untreated children do not survive into the second decade. The common cardiac phenotype seen in MPS I and other MPS types includes valve thickening and dysfunction, conduction abnormalities, coronary artery disease, and cardiomyopathy\u2014usually seen later in the disease course. A 15-month-old ex-35-weeker who presented with cardiomyopathy and left ventricular failure at the age of three weeks is presented here. Early evaluation and diagnosis with the help of newborn screening (NBS), followed by treatment with enzyme replacement therapy (ERT) and hematopoietic stem cell transplantation (HSCT), resulted in improvement of his cardiopulmonary status. In MPS I, an early cardiac phenotype is uncommon. Based on the evidence from the literature review for early neonatal cardiac phenotype, we propose that all infants with abnormal newborn screening for MPS I should receive cardiac screening with echocardiogram and NT-proB-type natriuretic peptide (BNP) during the initial evaluation.<\/jats:p>","DOI":"10.3390\/genes13081293","type":"journal-article","created":{"date-parts":[[2022,7,22]],"date-time":"2022-07-22T03:58:44Z","timestamp":1658462324000},"page":"1293","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Early Neonatal Cardiac Phenotype in Hurler Syndrome: Case Report and Literature Review"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2943-2136","authenticated-orcid":false,"given":"Nishitha R.","family":"Pillai","sequence":"first","affiliation":[{"name":"Advanced Therapies Program, M Health, University of Minnesota, Minneapolis, MN 55454, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alia","family":"Ahmed","sequence":"additional","affiliation":[{"name":"Advanced Therapies Program, M Health, University of Minnesota, Minneapolis, MN 55454, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Todd","family":"Vanyo","sequence":"additional","affiliation":[{"name":"Advanced Therapies Program, M Health, University of Minnesota, Minneapolis, MN 55454, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chester B.","family":"Whitley","sequence":"additional","affiliation":[{"name":"Advanced Therapies Program, M Health, University of Minnesota, Minneapolis, MN 55454, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,7,22]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1023\/A:1010379320378","article-title":"Enzyme replacement therapy in mucopolysaccharidosis type I: Progress and emerging difficulties","volume":"24","author":"Wraith","year":"2001","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_2","unstructured":"Neufeld, E.F.M.J. (2001). The Mucopolysaccharidoses, McGraw-Hill."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1750-1172-3-24","article-title":"The prevalence of and survival in Mucopolysaccharidosis I: Hurler, Hurler-Scheie and Scheie syndromes in the UK","volume":"3","author":"Moore","year":"2008","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Ojodu, J., Singh, S., Kellar-Guenther, Y., Yusuf, C., Jones, E., Wood, T., Baker, M., and Sontag, M.K. (2018). NewSTEPs: The Establishment of a National Newborn Screening Technical Assistance Resource Center. Int. J. Neonatal Screen., 4.","DOI":"10.3390\/ijns4010001"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/j.bbmt.2018.01.028","article-title":"Metabolic Syndrome and Cardiovascular Risk Factors after Hematopoietic Cell Transplantation in Severe Mucopolysaccharidosis Type I (Hurler Syndrome)","volume":"24","author":"Braunlin","year":"2018","journal-title":"Biol. Blood Marrow Transpl."},{"key":"ref_6","first-page":"Cd009354","article-title":"Enzyme replacement therapy with laronidase (Aldurazyme(\u00ae)) fortreating mucopolysaccharidosis type I","volume":"6","author":"Jameson","year":"2019","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s13023-017-0662-9","article-title":"Open issues in Mucopolysaccharidosis type I-Hurler","volume":"12","author":"Parini","year":"2017","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e226","DOI":"10.1016\/j.bbmt.2019.02.012","article-title":"Hematopoietic Stem Cell Transplantation for Mucopolysaccharidoses: Past, Present, and Future","volume":"25","author":"Taylor","year":"2019","journal-title":"Biol. Blood Marrow Transpl."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0925-4439(98)00046-5","article-title":"Genotype-phenotype correlations in mucopolysaccharidosis type I using enzyme kinetics, immunoquantification and in vitro turnover studies","volume":"1407","author":"Bunge","year":"1998","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/cge.13583","article-title":"Genotype-phenotype relationships in mucopolysaccharidosis type I (MPS I): Insights from the International MPS I Registry","volume":"96","author":"Clarke","year":"2019","journal-title":"Clin. Genet."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1093\/hmg\/3.6.861","article-title":"Mucopolysaccharidosis type I: Identification of 8 novel mutations and determination of the frequency of the two common alpha-L-iduronidase mutations (W402X and Q70X) among European patients","volume":"3","author":"Bunge","year":"1994","journal-title":"Hum. Mol. Genet."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.jmb.2004.03.012","article-title":"\u03b1-l-Iduronidase PrematureStop Codons and Potential Read-Through in Mucopolysaccharidosis Type I Patients","volume":"338","author":"Hein","year":"2004","journal-title":"J. Mol. Biol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1002\/humu.23301","article-title":"IDUA mutational profile and genotype-phenotype relationships in UK patients with Mucopolysaccharidosis Type I","volume":"38","author":"Ghosh","year":"2017","journal-title":"Hum. Mutat."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/humu.1380010412","article-title":"alpha-L-iduronidase mutations (Q70X and P533R) associate with a severe Hurler phenotype","volume":"1","author":"Scott","year":"1992","journal-title":"Hum. Mutat."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1002\/ajmg.a.32812","article-title":"Mucopolysaccharidosis type I in 21 Czech and Slovak patients: Mutation analysis suggests a functional importance of C-terminus of the IDUA protein","volume":"149","author":"Vazna","year":"2009","journal-title":"Am. J. Med. Genet. A"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13023-017-0583-7","article-title":"Early disease progression of Hurler syndrome","volume":"12","author":"Kiely","year":"2017","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1007\/s10545-011-9359-8","article-title":"Cardiac disease in patients with mucopolysaccharidosis: Presentation, diagnosis and management","volume":"34","author":"Braunlin","year":"2011","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_18","first-page":"1258","article-title":"Endocardial sclerosis in infancy associated with abnormal storage (gargoylism); report of a case in an infant, aged five months and review of the literature","volume":"24","author":"Strauss","year":"1957","journal-title":"J. Mt. Sinai Hosp. N. Y."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/S0022-3476(89)80565-7","article-title":"Hurler syndrome with cardiomyopathy in infancy","volume":"114","author":"Donaldson","year":"1989","journal-title":"J. Pediatr."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1007\/s10545-007-0613-z","article-title":"Successful treatment of severe heart failure in an infant with Hurler syndrome","volume":"30","author":"Hirth","year":"2007","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s10545-012-9500-3","article-title":"Management of mucopolysaccharidosis type IH (Hurler\u2019s syndrome) presenting in infancy with severe dilated cardiomyopathy: A single institution\u2019s experience","volume":"36","author":"Wiseman","year":"2013","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_22","first-page":"SC05","article-title":"Cardiovascular Abnormalities in Egyptian Children with Mucopolysaccharidoses","volume":"10","author":"Selim","year":"2016","journal-title":"J. Clin. Diagn Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"100714","DOI":"10.1016\/j.ymgmr.2021.100714","article-title":"Neonatal heart failure and noncompaction\/dilated cardiomyopathy from mucopolysaccharidosis. First description in literature","volume":"26","author":"Miselli","year":"2021","journal-title":"Mol. Genet. Metab. Rep."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1136\/adc.72.3.263","article-title":"The mucopolysaccharidoses: A clinical review and guide to management","volume":"72","author":"Wraith","year":"1995","journal-title":"Arch. Dis. Child."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.amjcard.2006.02.047","article-title":"Cardiac findings after enzyme replacement therapy for mucopolysaccharidosis type I","volume":"98","author":"Braunlin","year":"2006","journal-title":"Am. J. Cardiol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s13023-021-01743-2","article-title":"Natural progression of cardiac features and long-term effects of enzyme replacement therapy in Taiwanese patients with mucopolysaccharidosis II","volume":"16","author":"Lin","year":"2021","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.jpeds.2016.11.036","article-title":"Mucopolysaccharidosis Type I Newborn Screening: Best Practices for Diagnosis and Management","volume":"182","author":"Clarke","year":"2017","journal-title":"J. Pediatr."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Clarke, L.A., Dickson, P., Ellinwood, N.M., and Klein, T.L. (2020). Newborn Screening for Mucopolysaccharidosis I: Moving Forward Learning from Experience. Int. J. Neonatal Screen., 6.","DOI":"10.3390\/ijns6040091"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0140-6736(81)91046-1","article-title":"Reversal of clinical features of Hurler\u2019s disease and biochemical improvement after treatment by bone-marrow transplantation","volume":"2","author":"Hobbs","year":"1981","journal-title":"Lancet"},{"key":"ref_30","first-page":"7","article-title":"Bone marrow transplantation for Hurler syndrome: Assessment of metabolic correction","volume":"22","author":"Whitley","year":"1986","journal-title":"Birth Defects Orig. Artic. Ser."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/ajmg.1320460222","article-title":"Long-term outcome of Hurler syndrome following bone marrow transplantation","volume":"46","author":"Whitley","year":"1993","journal-title":"Am. J. Med. Genet."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/BF00710053","article-title":"Neuropsychological outcomes of several storage diseases with and without bone marrow transplantation","volume":"18","author":"Shapiro","year":"1995","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"4894","DOI":"10.1182\/blood.V87.11.4894.bloodjournal87114894","article-title":"Outcome of unrelated donor bone marrow transplantation in 40 children with Hurler syndrome","volume":"87","author":"Peters","year":"1996","journal-title":"Blood"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/sj.bmt.1704105","article-title":"Outcome of 27 patients with Hurler\u2019s syndrome transplanted from either related or unrelated haematopoietic stem cell sources","volume":"31","author":"Souillet","year":"2003","journal-title":"Bone Marrow Transpl."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/S0002-9149(03)00909-3","article-title":"Usefulness of bone marrow transplantation in the Hurler syndrome","volume":"92","author":"Braunlin","year":"2003","journal-title":"Am. J. Cardiol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1182\/blood-2014-11-606681","article-title":"Early HSCT corrects the skeleton in MPS","volume":"125","author":"Kurtzberg","year":"2015","journal-title":"Blood"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Kubaski, F., de Oliveira Poswar, F., Michelin-Tirelli, K., Matte, U.d.S., Horovitz, D.D., Barth, A.L., Baldo, G., Vairo, F., and Giugliani, R. (2020). Mucopolysaccharidosis Type I. Diagnostics, 10.","DOI":"10.3390\/diagnostics10030161"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s13023-020-01644-w","article-title":"Long term disease burden post-transplantation: Three decades of observations in 25 Hurler patients successfully treated with hematopoietic stem cell transplantation (HSCT)","volume":"16","author":"Guffon","year":"2021","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/sj.bmt.1705401","article-title":"Haematopoietic cell transplantation (HCT) in combination with enzyme replacement therapy (ERT) in patients with Hurler syndrome","volume":"38","author":"Boelens","year":"2006","journal-title":"Bone Marrow Transpl."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/sj.bmt.1705934","article-title":"Combination of enzyme replacement and hematopoietic stem cell transplantation as therapy for Hurler syndrome","volume":"41","author":"Tolar","year":"2008","journal-title":"Bone Marrow Transpl."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/s41390-019-0541-2","article-title":"Clinical trial of laronidase in Hurler syndrome after hematopoietic cell transplantation","volume":"87","author":"Polgreen","year":"2020","journal-title":"Pediatr. Res."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/BF00182044","article-title":"Structure, function, and pathology of proteoglycans and glycosaminoglycans in the urinary tract","volume":"12","author":"Hurst","year":"1994","journal-title":"World J. Urol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.cca.2020.05.035","article-title":"Comparison of dermatan sulfate and heparan sulfate concentrations in serum, cerebrospinal fluid and urine in patients with mucopolysaccharidosis type I receiving intravenous and intrathecal enzyme replacement therapy","volume":"508","author":"Zhang","year":"2020","journal-title":"Clin. Chim. Acta"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1056\/NEJMoa1516767","article-title":"Resolution of Disease Phenotypes Resulting from Multilocus Genomic Variation","volume":"376","author":"Posey","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1038\/s41436-019-0477-2","article-title":"A retrospective review of multiple findings in diagnostic exome sequencing: Half are distinct and half are overlapping diagnoses","volume":"21","author":"Smith","year":"2019","journal-title":"Genet. Med."}],"container-title":["Genes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4425\/13\/8\/1293\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:54:33Z","timestamp":1760140473000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4425\/13\/8\/1293"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,22]]},"references-count":45,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2022,8]]}},"alternative-id":["genes13081293"],"URL":"https:\/\/doi.org\/10.3390\/genes13081293","relation":{},"ISSN":["2073-4425"],"issn-type":[{"type":"electronic","value":"2073-4425"}],"subject":[],"published":{"date-parts":[[2022,7,22]]}}}